← Leaderboards
Thomas G Evans
University Of Rochester
$1,031,011
Attributed
$1,031,011
Total exposure
8
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,778,350 · 9
By mechanism
P30$747,339 · 2
R01$510,068 · 1
R43$263,787 · 1
R21$220,679 · 1
P51$36,477 · 1
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- John Jay Treanor$65,365,577
- Martin S Zand$41,716,435
- Ollivier Hyrien$5,420,823
- Edward E Walsh$4,308,125
- Byung-Kwang Yoo$697,250
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectVaccine DevelopmentClinical Trial Phase IVector VaccineHuman Therapy EvaluationDrug Screening /EvaluationHuman Immunodeficiency Virus 1AidsAids VaccinesBiomedical FacilityHiv InfectionsCellular ImmunityActive ImmunizationHepatitis BHepatitis VaccineHerpes Simplex DiseaseGlucocorticoidsCost EffectivenessAids TherapyAcyclovirCytomegalovirusEnzyme Linked Immunosorbent AssayGlycoproteins
Grant awards (12)
Immune Responses to CMV DNA Vaccination$510,068
R01 · FY2004 · AI
Development of a Cytomegalovirus DNA Vaccine$263,787
R43 · FY2004 · AI
HSV AMPLICON VECTORS FOR HIV VACCINE DEVELOPMENT$36,477
P51 · FY2003 · RR
ACYCLOVIR W/ GLUCOCORTICOSTEROIDS ON UV HERPES LABIALIS$0
M01 · FY2002 · RR
FLT 3 LIGAND AS ADJUVANT FOR HEPATITIS B VACCINATION$0
M01 · FY2002 · RR
CORE--CLINICAL INVESTIGATION$0
P30 · FY2002 · AI
Immunization Trials Designed to Induce Mucosal lmmunity$0
U19 · FY2002 · AI
North-Central California-Center For AIDS Research$747,339
P30 · FY2001 · AI
HSV Amplicon Vectors for HIV Vaccine Development$220,679
R21 · FY2001 · AI
CORE--CLINICAL INVESTIGATION$0
P30 · FY2001 · AI
ACYCLOVIR W/ GLUCOCORTICOSTEROIDS ON UV HERPES LABIALIS$0
M01 · FY2000 · RR
FLT 3 LIGAND AS ADJUVANT FOR HEPATITIS B VACCINATION$0
M01 · FY2000 · RR